Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026, Mar 2026, May 2026 and Aug 2026.
- Largest single sale: $2.4M (8,705 shares) of Labcorp on Mar 3, 2026. Filing
- Last sale before this period: Aug 11, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| DaVita (DVA) | Director | Sep 29, 2022 | Aug 18, 2026 |
| Labcorp (LH) | President & CEO, Director | Apr 3, 2013 | Aug 12, 2026 |
| Merck & Co. (MRK) | Former EVP & Pres-Global Human Health | May 6, 2010 | Nov 2, 2018 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 15, 2026, DaVita: 278 shares awarded. 1 filing: 1
- Aug 11, 2026, Labcorp: sold 4,669 shares for $1.5M, under a disclosed plan. 1 filing: 1
- May 15, 2026, DaVita: 250 shares awarded. 1 filing: 1
- May 11, 2026, Labcorp: sold 5,903 shares for $1.5M, under a disclosed plan. 1 filing: 1
- Mar 26, 2026, Labcorp: 58,470 shares awarded; 26,106 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.